Kenvue Inc. · NYSE (us_market)
Consumer Defensive · Household & Personal Products · United States
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2025-07-25$22.84 RISE2025-10-16$14.11 PEAK2025-11-28$17.35 126d | -38.2% 83d | Missed | Missed | — | — | +23.0% 43d | Missed |
DROP2024-12-02$24.26 RISE2025-02-06$19.80 PEAK2025-03-31$23.98 119d | -18.4% 66d | Missed | Missed | — | — | +21.1% 53d | Missed |
DROP2024-03-28$21.46 RISE2024-07-10$17.70 PEAK2024-09-13$23.39 169d | -17.5% 104d | Missed | Missed | — | — | +32.1% 65d | Missed |
DROP2023-06-22$26.55 RISE2023-10-27$18.21 PEAK2024-01-11$21.93 203d | -31.4% 127d | Missed | Missed | — | — | +20.4% 76d | Missed |
AVO closes the Calavo deal, adding guacamole and new produce lines. Watch integration and synergy goals for the stock now.
CL balances pricing and volume growth as emerging markets and innovation support sales momentum.
Broad US equity markets declined during the quarter, with the Russell 3000 falling 3.96%, while performance across the cap spectrum was mixed. Read more here.
GECC, KVUE and TNET made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 26, 2026.
GECC, KVUE and TNET made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 26, 2026.
Kimberly-Clark (KMB), near 52-week lows, offers a 5.2% yield, Q1 organic growth, and Kenvue merger synergiesâsee why itâs a Buy and act now.
Kimberly-Clarkâs 2026 free cash flow outlook, Kenvue acquisition risks, synergy targets and margin pressure from rising costs.
Dividend growth among Kings accelerated to 3.71%, with notable increases from W.W. Grainger, Parker-Hannifin, and RLI Corp. Read more on Dividend Kings here.
KVUE vs. LRLCY: Which Stock Is the Better Value Option?
KVUE vs. LRLCY: Which Stock Is the Better Value Option?
The Asia Pacific Dental Federation (APDF) has released The Power of Prevention: Evidence-Based Guidelines for Self-Oral Care, a landmark white paper setting out what effective daily oral care should look like and why it matters well beyond your teeth.
Kimberly-Clark (NasdaqGS:KMB) announced an agreement to acquire Kenvue, expanding its reach in consumer health brands. The company is realigning its joint venture with Suzano, which includes plans to divest lower-growth operations. Kimberly-Clark is launching Pull-Ups Learning Layer technology nationwide, targeting parents focused on potty training support. Kimberly-Clark, best known for tissues, diapers and personal care products, is using the Kenvue deal to lean further into branded...
Kimberly-Clark (NasdaqGS:KMB) announced an agreement to acquire Kenvue, expanding its reach in consumer health brands. The company is realigning its joint venture with Suzano, which includes plans to divest lower-growth operations. Kimberly-Clark is launching Pull-Ups Learning Layer technology nationwide, targeting parents focused on potty training support. Kimberly-Clark, best known for tissues, diapers and personal care products, is using the Kenvue deal to lean further into branded...
The arrangement will use Greyparrot’s Deepnest system to help Kenvue replace theoretical "design-for-recycling" assumptions.
The arrangement will use Greyparrot’s Deepnest system to help Kenvue replace theoretical "design-for-recycling" assumptions.
SUMMIT, N.J., May 20, 2026--Greyparrot, the leader in AI-powered waste intelligence, announces a collaboration with Kenvue, the world’s largest pure-play consumer health company.
The collaboration spotlights use cases for AI in packaging, such as pinpointing the optimal hue for shampoo bottles to ensure recyclability. Identifying design changes gains importance as the packaging regulation landscape widens.
The collaboration spotlights use cases for AI in packaging, such as pinpointing the optimal hue for shampoo bottles to ensure recyclability. Identifying design changes gains importance as the packaging regulation landscape widens.
- 13F Filing
Kimberly-Clark Corp (NYSE:KMB, XETRA:KMY) has earned a repeat ‘Buy’ rating and $120 price objective from Bank of America analysts, who believe that the company’s acquisition of Kenvue assets could create long-term value despite near-term integration challenges. The analysts said the deal...
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| KVUE | -0.86% | -8.52% | +0.17% | -27.61% |
| XLP | -1.50% | -6.54% | +6.73% | +0.10% |
| Alpha (stock − sector) | +0.64% | -1.98% | -6.56% | -27.70% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 135.09M | $2.33B | 0.12% | Added+43.5% | 2026-03-31 |
| StateStreet | passive | 119.57M | $2.06B | 0.07% | Added+0.6% | 2026-03-31 |
| DEShaw | quant | 26.28M | $453.10M | 0.27% | Trimmed-0.6% | 2026-03-31 |
| RenTech | quant | 4.14M | $71.40M | 0.11% | New | 2026-03-31 |
| Soros | macro | 3.16M | $54.43M | 0.60% | Added+153.3% | 2026-03-31 |
| Wellington | fundamental | 2.92M | $50.38M | 0.01% | Added+24.7% | 2026-03-31 |
| CapResearch | fundamental | 1.59M | $27.45M | 0.00% | Unchanged | 2026-03-31 |
| Citadel | multi-strat | 461.3K | $7.95M | 0.01% | Trimmed-40.9% | 2026-03-31 |
| Bridgewater | macro | 125.0K | $2.15M | 0.01% | Trimmed-36.3% | 2026-03-31 |
| TRowePrice | fundamental | 19.62M | $338.25K | 0.04% | Trimmed-0.7% | 2026-03-31 |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-26 | Smith Jeffrey C | Director | A Grant / award(deriv) | 10,309 | $17.46 | +$180.0K |
| 2026-05-26 | Godbole Seemantini | Director | A Grant / award(deriv) | 10,309 | $17.46 | +$180.0K |
| 2026-05-26 | Mann Erica L | Director | A Grant / award(deriv) | 10,309 | $17.46 | +$180.0K |
| 2026-05-26 | ALLISON RICHARD E JR | Director | A Grant / award(deriv) | 10,309 | $17.46 | +$180.0K |
| 2026-05-26 | PAWLUS KATHLEEN M | Director | A Grant / award(deriv) | 10,309 | $17.46 | +$180.0K |
| 2026-05-26 | Healey Melanie | Director | A Grant / award(deriv) | 10,309 | $17.46 | +$180.0K |
| 2026-05-26 | Curado Gomes de Lemos Leonardo | Group President LATAM | M Option exercise(deriv) | 24,248 | — | +$0 |
| 2026-05-26 | Curado Gomes de Lemos Leonardo | Group President LATAM | F Tax withholding | 7,141 | $17.43 | −$124.5K |
| 2026-05-26 | Curado Gomes de Lemos Leonardo | Group President LATAM | M Option exercise | 24,248 | — | +$0 |
| 2026-05-26 | Sneed Michael E | Director | A Grant / award(deriv) | 10,309 | $17.46 | +$180.0K |
| 2026-05-26 | PRABHU VASANT M | Director | A Grant / award(deriv) | 10,309 | $17.46 | +$180.0K |
| 2026-05-26 | MERLO LARRY J | Director | A Grant / award(deriv) | 16,036 | $17.46 | +$280.0K |
| 2026-05-26 | HOLDEN BETSY D | Director | A Grant / award(deriv) | 10,309 | $17.46 | +$180.0K |
| 2026-05-26 | Hofstetter Sarah | Director | A Grant / award(deriv) | 10,309 | $17.46 | +$180.0K |
| 2026-05-12 | Orlando Matthew | General Counsel | S Open-market sale | 38,491 | $17.66 | −$679.7K |
| 2026-04-01 | Smith Jeffrey C | Director | A Grant / award(deriv) | 1,331 | — | — |
| 2026-03-31 | ALLISON RICHARD E JR | Director | A Grant / award(deriv) | 1,331 | — | — |
| 2026-03-12 | Lawson Carlton | Group President EMEA & LA | M Option exercise(deriv) | 6,158 | — | +$0 |
| 2026-03-12 | Lawson Carlton | Group President EMEA & LA | M Option exercise | 6,158 | — | +$0 |
| 2026-03-12 | Alvarado Luani | Chief People Officer | M Option exercise(deriv) | 697 | — | +$0 |
| 2026-03-12 | Alvarado Luani | Chief People Officer | M Option exercise(deriv) | 3,525 | — | +$0 |
| 2026-03-12 | Alvarado Luani | Chief People Officer | F Tax withholding | 357 | $18.16 | −$6.5K |
| 2026-03-12 | Alvarado Luani | Chief People Officer | M Option exercise | 697 | — | +$0 |
| 2026-03-12 | Alvarado Luani | Chief People Officer | F Tax withholding | 1,721 | $17.96 | −$30.9K |
| 2026-03-12 | Alvarado Luani | Chief People Officer | M Option exercise | 3,525 | — | +$0 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | 0.32 | — | — |
| 2026-05-07 | 0.26 | 0.32 | +23.03% |
| 2026-02-17 | 0.22 | 0.27 | +21.24% |
| 2025-11-03 | 0.26 | 0.28 | +5.72% |
| 2025-08-07 | 0.28 | 0.29 | +2.22% |
| 2025-05-08 | 0.23 | 0.24 | +5.42% |
| 2025-02-06 | 0.26 | 0.26 | +1.49% |
| 2024-11-07 | 0.27 | 0.28 | +2.98% |
| 2024-08-06 | 0.28 | 0.32 | +15.65% |
| 2024-05-07 | 0.25 | 0.28 | +10.35% |
| 2024-02-08 | 0.28 | 0.31 | +9.85% |
| 2023-10-26 | 0.31 | 0.31 | -1.44% |
| 2023-07-20 | 0.30 | 0.32 | +6.86% |